Abstract Objective To study new biomarkers for the early diagnosis of retinopathy of prematurity (ROP) by analyzing the differences in blood metabolites based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) and metabolomics. Methods Dried blood spots were collected from 21 infants with ROP (ROP group) and 21 infants without ROP (non-ROP group) who were hospitalized in the Sixth Affiliated Hospital of Sun Yat-sen University from January 2013 to December 2016. LC-MS/MS was used to measure the metabolites, and orthogonal partial least squares-discriminant analysis was used to search for differentially expressed metabolites and biomarkers. Results There was a significant difference in blood metabolic profiles between the ROP and non-ROP groups. The pattern recognition analysis, Score-plot, and weight analysis obtained 10 amino acids with a relatively large difference. Further statistical analysis showed that the ROP group had significant increases in blood levels of glutamic acid, leucine, aspartic acid, ornithine, and glycine compared with the non-ROP group (P<0.05). The receiver operating characteristic curve analysis showed that glutamic acid and ornithine had the highest value in diagnosing ROP. Conclusions Blood metabolites in preterm infants with ROP are different from those without ROP. Glutamic acid and ornithine are the metabolic markers for diagnosing ROP. LC-MS/MS combined with metabolomics analysis has a potential application value in the early identification and diagnosis of ROP.
YANG Qiu-Ping,LI Si-Tao,HAO Hu et al. Blood metabolites in preterm infants with retinopathy of prematurity based on tandem mass spectrometry: a preliminary study[J]. CJCP, 2023, 25(2): 140-146.
YANG Qiu-Ping,LI Si-Tao,HAO Hu et al. Blood metabolites in preterm infants with retinopathy of prematurity based on tandem mass spectrometry: a preliminary study[J]. CJCP, 2023, 25(2): 140-146.
Teoh ST, Leimanis-Laurens ML, Comstock SS, et al. Combined plasma and urinary metabolomics uncover metabolic perturbations associated with severe respiratory syncytial viral infection and future development of asthma in infant patients[J]. Metabolites, 2022, 12(2): 178. PMID: 35208252. PMCID: PMC8875115. DOI: 10.3390/metabo12020178.
Pieragostino D, Cicalini I, Di Michele S, et al. A case of suspected hyperphenylalaninemia at newborn screening by tandem mass spectrometry during total parenteral nutrition[J]. Metabolites, 2020, 10(2): 44. PMID: 31991569. PMCID: PMC7074497. DOI: 10.3390/metabo10020044.
Cicalini I, Tumini S, Guidone PI, et al. Serum steroid pro?ling by liquid chromatography-tandem mass spectrometry for the rapid confirmation and early treatment of congenital adrenal hyperplasia: a neonatal case report[J]. Metabolites, 2019, 9(12): 284. PMID: 31766536. PMCID: PMC6950672. DOI: 10.3390/metabo9120284.
Zhou Y, Xu Y, Zhang X, et al. Plasma metabolites in treatment-requiring retinopathy of prematurity: potential biomarkers identified by metabolomics[J]. Exp Eye Res, 2020, 199: 108198. PMID: 32828955. DOI: 10.1016/j.exer.2020.108198.
Nilsson AK, Andersson MX, Sj?bom U, et al. Sphingolipidomics of serum in extremely preterm infants: association between low sphingosine-1-phosphate levels and severe retinopathy of prematurity[J]. Biochim Biophys Acta Mol Cell Biol Lipids, 2021, 1866(7): 158939. PMID: 33862236. PMCID: PMC8633973. DOI: 10.1016/j.bbalip.2021.158939.
Ozcan Y, Huseyin G, Sonmez K. Evaluation of plasma amino acid levels in preterm infants and their potential correlation with retinopathy of prematurity[J]. J Ophthalmol, 2020, 2020: 8026547. PMID: 33489343. PMCID: PMC7801939. DOI: 10.1155/2020/8026547.
Mikulski T, Dabrowski J, Hilgier W, et al. Effects of supplementation with branched chain amino acids and ornithine aspartate on plasma ammonia and central fatigue during exercise in healthy men[J]. Folia Neuropathol, 2015, 53(4): 377-386. PMID: 26785372. DOI: 10.5114/fn.2015.56552.
Vandekeere S, Dubois C, Kalucka J, et al. Serine synthesis via PHGDH is essential for heme production in endothelial cells[J]. Cell Metab, 2018, 28(4): 573-587.e13. PMID: 30017355. DOI: 10.1016/j.cmet.2018.06.009.